Essential aspects of the follow-up after acute pulmonary embolism: An illustrated review
- PMID: 32864549
- PMCID: PMC7443426
- DOI: 10.1002/rth2.12404
Essential aspects of the follow-up after acute pulmonary embolism: An illustrated review
Abstract
Care for patients with acute pulmonary embolism (PE) involves more than determination of the duration of anticoagulant therapy. After choosing the optimal initial management strategy based on modern risk stratification schemes, patients require focused attention aimed at prevention of major bleeding, identification of underlying (malignant) disease, prevention of cardiovascular disease, and monitoring for long-term complications. The most frequent complication of PE is the so-called "post-PE syndrome," a phenomenon of permanent functional limitations after PE occurring in up to 50% of patients. The post-PE syndrome is caused by persistent deconditioning, anxiety, and/or ventilatory or circulatory impairment as a result of acute PE. The most severe and most feared presentation of the post-PE syndrome is chronic thromboembolic pulmonary hypertension (CTEPH), a deadly disease if it remains untreated. While CTEPH may be successfully treated with pulmonary endarterectomy, balloon pulmonary angioplasty, and/or pulmonary hypertension drugs, the major challenge is to diagnose CTEPH at an early stage. Poor awareness for the post-PE syndrome and in particular for CTEPH, high prevalence of persistent symptoms after PE and inefficient application of diagnostic tests in clinical practice all contribute to an unacceptable diagnostic delay and underdiagnosis. Its consequences are dire: increased mortality in patients with CTEPH, and excess health care costs, higher prevalence of depression, more unemployment and poorer quality of life in patients with post-PE syndrome in general. In this review, we provide an overview of the incidence and impact of the post-PE syndrome, and illustrate the clinical presentation, optimal diagnostic strategy as well as therapeutic options.
Keywords: complications; early diagnosis; prognosis; pulmonary embolism; pulmonary hypertension; venous thromboembolism.
© 2020 The Authors. Research and Practice in Thrombosis and Haemostasis published by Wiley Periodicals LLC on behalf of International Society on Thrombosis and Haemostasis.
References
-
- Konstantinides SV, Meyer G, Becattini C, Bueno H, Geersing GJ, Harjola VP, et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the ERS: The Task Force for the diagnosis and management of acute pulmonary embolism of the ESC. Eur Respir J. 2020;41(4):543–603. - PubMed
-
- den Exter PL, van der Hulle T, Lankeit M, Huisman MV, Klok FA. Long‐term clinical course of acute pulmonary embolism. Blood Rev. 2013;27(4):185–92. - PubMed
-
- Klok FA, Huisman MV. How I assess and manage the risk of bleeding during treatment of patients with venous thromboembolism. Blood. 2020;135(10):724–734. - PubMed
-
- Kline JA, Steuerwald MT, Marchick MR, Hernandez‐Nino J, Rose GA. Prospective evaluation of right ventricular function and functional status 6 months after acute submassive pulmonary embolism: frequency of persistent or subsequent elevation in estimated pulmonary artery pressure. Chest. 2009;136(5):1202–10. - PMC - PubMed
-
- Stevinson BG, Hernandez‐Nino J, Rose G, Kline JA. Echocardiographic and functional cardiopulmonary problems 6 months after first‐time pulmonary embolism in previously healthy patients. Eur Heart J. 2007;28(20):2517–24. - PubMed
Publication types
LinkOut - more resources
Full Text Sources